Clinical Trial Details

Trial ID: L0883
Source ID: NCT02491229
Associated Drug: Hepafast
Title: Clinical Trial for Investigating the Effects of "Hepafast" on Non-alcoholic Fatty Liver Disease (NAFLD)
Acronym: --
Status: Not recruiting
Study Results: No Results Available
Results: --
Conditions: Non-alcoholic Fatty Liver Disease (NAFLD);Obesity
Interventions: Other: Hepafast;Other: LOGI diet
Outcome Measures: change from baseline in hepatorenal index at two weeks, six weeks and twelve weeks after starting a defined way of nutritionchange from baseline in fatty liver index at two weeks, six weeks and twelve weeks after starting a defined way of nutrition;change from baseline in the classification of non-alcoholic fatty liver disease (NAFLD) based on ultrasound at two weeks, six weeks and twelve weeks after starting a defined way of nutrition;change from baseline in body weight at two weeks, six weeks and twelve weeks after starting a defined way of nutrition;change from baseline in blood pressure (systolic and diastolic) at two weeks, six weeks and twelve weeks after starting a defined way of nutrition;change from baseline in GGT at two weeks, six weeks and twelve weeks after starting a defined way of nutrition;change from baseline in GOT at two weeks, six weeks and twelve weeks after starting a defined way of nutrition;change from baseline in GPT at two weeks, six weeks and twelve weeks after starting a defined way of nutrition;change from baseline in AP at two weeks, six weeks and twelve weeks after starting a defined way of nutrition;change from baseline in triglycerides at two weeks, six weeks and twelve weeks after starting a defined way of nutrition;change from baseline in HDL cholesterol at two weeks, six weeks and twelve weeks after starting a defined way of nutrition;change from baseline in LDL cholesterol at two weeks, six weeks and twelve weeks after starting a defined way of nutrition;change from baseline in fasting glucose at two weeks, six weeks and twelve weeks after starting a defined way of nutrition;change from baseline in insulin at two weeks, six weeks and twelve weeks after starting a defined way of nutrition;change from baseline in HbA1c at two weeks, six weeks and twelve weeks after starting a defined way of nutrition;change from baseline in hsCRP at two weeks, six weeks and twelve weeks after starting a defined way of nutrition
Sponsor/Collaborators: University of Hohenheim
Gender: All
Age: 18 Years65 Years
Phases: Not applicable
Enrollment: 40
Study Type: Interventional
Study Designs: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Start Date: 03/02/2015
Completion Date: --
Results First Posted: --
Last Update Posted: 25 January 2016
Locations: Germany
URL: https://clinicaltrials.gov/show/NCT02491229